Market Flux
Open the Terminal

Market Flux Event

Latigo Biotherapeutics Raises $345.6 Million in IPO at $18 Per Share

By Market Flux··1 min read

Non-opioid painkiller developer Latigo Biotherapeutics completed its initial public offering, pricing 19.2 million shares at $18 each to raise $345.6 million. The company now trades on NASDAQ under ticker LTGO.

© AI-generated summary is provided by Market Flux

Sources

  1. BloombergNon-Opioid Painkiller Maker Latigo Raises $345.6 Million in IPO
  2. InvestingLatigo Biotherapeutics prices $345.6M IPO at $18 per share